BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 24614069)

  • 1. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.
    Walsh J; Cram A; Woertz K; Breitkreutz J; Winzenburg G; Turner R; Tuleu C;
    Adv Drug Deliv Rev; 2014 Jun; 73():14-33. PubMed ID: 24614069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taste-masking assessment of solid oral dosage forms--a critical review.
    Pein M; Preis M; Eckert C; Kiene FE
    Int J Pharm; 2014 Apr; 465(1-2):239-54. PubMed ID: 24509066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is rat a good model for assessment of particulate-based taste-masked formulations?
    Ali J; Chiang M; Lee JB; Voronin GO; Bennett J; Cram A; Kagan L; Garnett MC; Roberts CJ; Gershkovich P
    Eur J Pharm Biopharm; 2020 Jan; 146():1-9. PubMed ID: 31726218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on the taste masking of bitter APIs: hot-melt extrusion (HME) evaluation.
    Maniruzzaman M; Boateng JS; Chowdhry BZ; Snowden MJ; Douroumis D
    Drug Dev Ind Pharm; 2014 Feb; 40(2):145-56. PubMed ID: 23763436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent landscape of pediatric-friendly oral dosage forms and administration devices.
    Karavasili C; Gkaragkounis A; Fatouros DG
    Expert Opin Ther Pat; 2021 Jul; 31(7):663-686. PubMed ID: 33605825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat Palatability Study for Taste Assessment of Caffeine Citrate Formulation Prepared via Hot-Melt Extrusion Technology.
    Tiwari RV; Polk AN; Patil H; Ye X; Pimparade MB; Repka MA
    AAPS PharmSciTech; 2017 Feb; 18(2):341-348. PubMed ID: 26573158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Paediatric Formulation Initiative (EuPFI)-Formulating Ideas for Better Medicines for Children.
    Salunke S; Liu F; Batchelor H; Walsh J; Turner R; Ju TR; Tuleu C;
    AAPS PharmSciTech; 2017 Feb; 18(2):257-262. PubMed ID: 27422653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taste-masking methods in multiparticulate dosage forms with a focus on poorly soluble drugs.
    Simšič T; Planinšek O; Baumgartner A
    Acta Pharm; 2024 Jun; 74(2):177-199. PubMed ID: 38815202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of the bitter taste of drugs by complexation with cyclodextrins: applications, evaluations and mechanisms.
    Arima H; Higashi T; Motoyama K
    Ther Deliv; 2012 May; 3(5):633-44. PubMed ID: 22834407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
    Thabet Y; Klingmann V; Breitkreutz J
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of medicines for children.
    Nunn T; Williams J
    Br J Clin Pharmacol; 2005 Jun; 59(6):674-6. PubMed ID: 15948931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Taste-masking possibilities in solid dosage forms].
    Szakonyi G; Zelkó R
    Acta Pharm Hung; 2012; 82(2):81-90. PubMed ID: 22870781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taste Masking Approaches for Medicines.
    Faisal W; Farag F; Abdellatif AAH; Abbas A
    Curr Drug Deliv; 2018 Feb; 15(2):167-185. PubMed ID: 29034835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific interactions between diphenhydramine and alpha-helical poly(glutamic acid)--a new ion-pairing complex for taste masking and pH-controlled diphenhydramine release.
    Agresti C; Tu Z; Ng C; Yang Y; Liang JF
    Eur J Pharm Biopharm; 2008 Sep; 70(1):226-33. PubMed ID: 18514496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric drug development: formulation considerations.
    Ali AA; Charoo NA; Abdallah DB
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population.
    Venables R; Batchelor H; Hodson J; Stirling H; Marriott J
    Int J Pharm; 2015 Mar; 480(1-2):55-62. PubMed ID: 25601436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution methodology for taste masked oral dosage forms.
    Gittings S; Turnbull N; Roberts CJ; Gershkovich P
    J Control Release; 2014 Jan; 173():32-42. PubMed ID: 24184344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric formulation issues identified in Paediatric Investigation Plans.
    Quijano Ruiz B; Desfontaine E; Arenas-López S; Wang S
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):25-30. PubMed ID: 24308789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Applications of Cyclodextrins as Taste-Masking Excipients for Pharmaceutical Purposes.
    Adamkiewicz L; Szeleszczuk Ł
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
    Freerks L; Sommerfeldt J; Löper PC; Klein S
    Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.